If you invested in in
A $1,000 investment in SPDR S&P Biotech ETF (XBI) in January 2016 would be worth $2,667 as of June 2026 with dividends reinvested — 9.9% a year. Use the dropdowns above to try any amount, ticker, or starting month back to February 2006.
Growth of $1,000 in XBI since January 2016
dividends reinvested · monthlySPDR S&P Biotech ETF (XBI). Total return approximated via dividend- and split-adjusted closes (dividends reinvested, no taxes or fees). Not investment advice.
$1,000 invested in XBI, by starting year
| Invested in | Worth today (div. reinvested) | Price-only | Multiple | Annualized |
|---|---|---|---|---|
| 2006 | $7,914 | $7,492 | 7.9× | 10.7% |
| 2007 | $8,804 | $8,334 | 8.8× | 11.9% |
| 2008 | $7,484 | $7,106 | 7.5× | 11.6% |
| 2009 | $7,858 | $7,546 | 7.9× | 12.6% |
| 2010 | $7,477 | $7,204 | 7.5× | 13.1% |
| 2011 | $6,687 | $6,443 | 6.7× | 13.2% |
| 2012 | $5,395 | $5,198 | 5.4× | 12.5% |
| 2013 | $4,337 | $4,188 | 4.3× | 11.6% |
| 2014 | $2,740 | $2,651 | 2.7× | 8.5% |
| 2015 | $2,037 | $1,995 | 2.0× | 6.5% |
| 2016 | $2,667 | $2,626 | 2.7× | 9.9% |
| 2017 | $2,071 | $2,045 | 2.1× | 8.1% |
| 2018 | $1,436 | $1,422 | 1.4× | 4.4% |
| 2019 | $1,600 | $1,588 | 1.6× | 6.6% |
| 2020 | $1,501 | $1,489 | 1.5× | 6.6% |
| 2021 | $873 | $868 | 0.9× | -2.5% |
| 2022 | $1,428 | $1,421 | 1.4× | 8.5% |
| 2023 | $1,501 | $1,493 | 1.5× | 12.9% |
| 2024 | $1,526 | $1,518 | 1.5× | 19.6% |
| 2025 | $1,438 | $1,432 | 1.4× | 30.7% |
Methodology
Investments are assumed made at the first trading day's close of the chosen year. "Dividends reinvested" uses split- and dividend-adjusted closes (a standard total-return approximation; taxes and fees excluded). "Price-only" uses split-adjusted closes. XBI data begins February 2006; values as of June 2026 and refresh daily. Past performance does not predict future returns; not investment advice.
See the live XBI chart and fundamentals on the XBI quote page or compare with the same investment in SPY.